UPDATE: Mizuho Securities Downgrades Pacira Pharmaceuticals (PCRX) to Underperform; High Price for Mature Business

February 1, 2019 6:12 AM EST Send to a Friend
(Updated - February 1, 2019 6:25 AM EST)

(updated to add analyst comments)Mizuho Securities analyst Irina Koffler downgraded Pacira ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login